Dan Suesskind

Global CFO of Teva – $45 billion market cap company from 1987-2008. Among his achievements – registered Teva on NASDAQ, multiple successful acquisitions and raised over $6 billion in the U.S. Started when sales were $28 million left when they reached $11 billion.

Elaine Campbell

A retired senior executive with over 30 years of experience in the pharmaceutical and chemical industry. Has broad commercial experience in sales and marketing, including early and pre-launch product development, product launch, and life cycle management. Her experience includes Global and North American roles. President of AstraZeneca Canada from 2012-2015.

Dr. Ferid Murad, MD, PhD

Dr. Murad was a co-recipient of the 1998 Nobel Prize in Physiology or Medicine for the discovery that nitric oxide acts as a signaling molecule in the cardiovascular system. Dr. Murad along with Robert F. Furchgott, PhD,  and Louis J. Ignarro  PhD, identified an entirely new mechanism that explains how blood vessels in the body relax and widen. 

Dr. Murad was Chief of Medicine at the Palo Alto VA Medical Center (1981–1986), Associate Chairman, Dept. of Medicine, Stanford University (1984–1986), and Acting Chairman, Dept. of Medicine and Acting Division Chief, Division of Respiratory Medicine from 1986-1988.

Udi Daon

Mr. Daon is an award-winning serial innovator and entrepreneur with 20 years experience in the invention and commercialization of med-tech products.  He holds more than 70 patents in prosecution worldwide. He led and advised teams and companies and headed the commercial launch of more than 10 products.  Mr. Daon has multi-million dollar licensing and sales cycles experience.

logged in